In this issue:
ESMO guideline interim update: Targeted therapy in ALL
MZL: 2023 update on diagnosis and management
DOACs for primary thromboprophylaxis in patients with MM
In vivo hematopoietic stem cell modification by mRNA delivery
Australian clinical trial aims to prevent complications in paediatric cancers
New AusPAR for turoctocog alfa pegol (Esperoct)
Eltrombopag submitted for PBAC review
Supply of Ordine (morphine) to cease
Urgent call for type O blood donors in Australia
Abelacimab trial stopped early due to ‘overwhelming’ bleeding reduction
Patients with SCD are now living a decade longer
ASCO research statement recommends measuring ovarian toxicity in clinical trials
COVID-19 resources
Conferences, workshops and CPD
Please login below to download this issue (PDF)